Related Experiment Video
Updated: Sep 13, 2025

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
Published on: November 11, 2018
Structure and mechanism of the RalGAP tumor suppressor complex
René Rasche1, Björn Udo Klink2,3, Lisa Helene Apken4
1Institute of Biochemistry, University of Münster, Münster, Germany.
Abstract:
The RalGAP (GTPase activating protein) complexes are negative regulators of the Ral GTPases and thus crucial components that counteract oncogenic Ras signaling. However, no structural information on the architecture of this tumor suppressor complex is available hampering a mechanistic understanding of its functionality. Here, we present a cryo-EM structure of RalGAP that reveals an extended 58 nm tetrameric architecture comprising two heterodimers of the RalGAPα and RalGAPβ subunits. We show that the catalytic domain of RalGAPα requires stabilization by a unique domain of RalGAPβ, providing the molecular basis for why RalGAP complexes are obligatory heterodimers. Formation of RalGAP tetramers is not required for activity in vitro, but essential for function of the complex in vivo. Structural analysis of RalGAP subunit variants reported in cancer patients suggests effects on complex formation and thus functional relevance, emphasizing the significance of the obtained structural information for medical research.
Insights
Ral GTPase activating protein (RalGAP) complexes suppress cancer-driving Ras signals. We determined the RalGAP structure, revealing its tetrameric architecture and how subunits stabilize each other for in vivo function.
Area of Science:
- Structural biology
- Molecular mechanisms
- Cancer research
Background:
- Ral GTPase activating protein (RalGAP) complexes are critical negative regulators of Ral GTPases.
- They counteract oncogenic Ras signaling, acting as tumor suppressors.
- Lack of structural data hindered understanding of RalGAP complex functionality.
Purpose of the Study:
- To elucidate the structural architecture of RalGAP complexes.
- To understand the molecular basis of RalGAP complex assembly and function.
- To investigate the relevance of structural findings for cancer-associated mutations.
Main Methods:
- Cryo-electron microscopy (cryo-EM) to determine the structure of RalGAP.
- Biochemical assays to assess in vitro and in vivo activity.
- Analysis of cancer patient-reported RalGAP subunit variants.
Main Results:
- A cryo-EM structure revealed an extended 58 nm tetrameric architecture of RalGAP, composed of two heterodimers of RalGAPα and RalGAPβ subunits.
- A unique domain of RalGAPβ stabilizes the catalytic domain of RalGAPα, explaining the necessity for heterodimer formation.
- While tetramer formation is not essential for in vitro activity, it is crucial for in vivo function.
- Analysis of cancer variants suggests impaired complex formation, impacting function.
Conclusions:
- The determined RalGAP structure provides molecular insights into its tumor suppressor function.
- Structural findings highlight the importance of RalGAP complex assembly for in vivo activity.
- The study emphasizes the clinical relevance of RalGAP structural biology in understanding cancer.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a...
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Rab Cascades
GTPases and their Regulation
Large G-proteins,...
Negative Regulator Molecules

